Skip to main content

Articles

Clinical, Original Research

Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy

Lori A. Leslie, MD; Bruno Emond, MSc; Marie-Hélène Lafeuille, MA; Maude Vermette-Laforme, BSc; Patrick Lefebvre, MA; Qing Huang, PhD, MHS

Business, Original Research

Budget Impact of Intravenous Cetirizine Hydrochloride for the Treatment of Acute Urticaria in the Emergency Department Setting

Lisa M. Bloudek, PharmD, MS; LoAn K. Ho, PharmD; Neha Kapur, PharmD; Lonnie D. Brent, PharmD

Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma

Conference Highlights ASCO

Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions

Conference Highlights ASCO

PD-1 Inhibition with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer

Tafinlar plus Mekinist First Tumor-Agnostic Therapy Approved for Any Unresectable or Metastatic Solid Tumors with BRAF Mutation

Xalkori Now FDA Approved for the Treatment of ALK-Positive Inflammatory Myofibroblastic Tumor

Oncologists’ Common Misconceptions About Biosimilars Revealed in a Recent Survey

Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer

Oncology Overview

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45

7
8
9
10
11
12
13

Page 10 of 246
Results 91 - 100 of 2458